A comparison of cilostazol and pentoxifylline for treating intermittent claudication
Top Cited Papers
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 109 (7) , 523-530
- https://doi.org/10.1016/s0002-9343(00)00569-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A New Pharmacological Treatment for Intermittent Claudication:Archives of internal medicine (1960), 1999
- Effect of the Novel Antiplatelet Agent Cilostazol on Plasma Lipoproteins in Patients With Intermittent ClaudicationArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Cilostazol Has Beneficial Effects in Treatment of Intermittent ClaudicationCirculation, 1998
- Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular diseaseJournal of Vascular Surgery, 1998
- Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical ReviewCirculation, 1996
- Pentoxifylline and Intermittent ClaudicationJournal of Cardiovascular Pharmacology, 1995
- Proposed design for a double blinded trial to evaluate medications for treatment of intermittent claudicationJournal of Vascular Surgery, 1992
- The Evaluation of Exercise Performance in Patients with Peripheral Vascular DiseaseJournal of Cardiopulmonary Rehabilitation, 1988
- Suggested standards for reports dealing with lower extremity ischemiaJournal of Vascular Surgery, 1986
- Prevalence of Intermittent Claudication and Its Effect on MortalityActa Medica Scandinavica, 1982